A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

~47 mi. (Ponderano, Italy, +383 more cities)

Ospedale Degli Infermi Di Biella; Reparto Oncologia Medica

ER Negative, +2 more biomarkers

Breast Carcinoma

atezolizumab, +4 more drugs

chemotherapy, +1 more type

MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

~47 mi. (Ponderano, Italy, +34 more cities)

Ospedale degli Infermi

MS4A1 Expression

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +2 more conditions

ibrutinib, +1 more drug

immunotherapy, +1 more type

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

~66 mi. (Turin, Italy, +44 more cities)

AOU City of Health and Science of Turin

BCL2 Fusion, +2 more biomarkers

Diffuse Large B-Cell Lymphoma, +3 more conditions

cisplatin, +5 more drugs

chemotherapy, +3 more types

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~70 mi. (Orbassano, Italy, +93 more cities)

AOU San Luigi Gonzaga di Orbassano ( Site 0595)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~70 mi. (Orbassano, Italy, +172 more cities)

Azienda Sanitaria Ospedaliera S Luigi Gonzaga

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

~70 mi. (Orbassano, Italy, +190 more cities)

AOU San Luigi Gonzaga

ATM Loss, +27 more biomarkers

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~70 mi. (Orbassano, Italy, +93 more cities)

Ospedale San Luigi Gonzaga ( Site 1405)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy

~70 mi. (Orbassano, Italy, +120 more cities)

A.O. UNIVERSITARIA S. LUIGI GONZAGA; Oncologia Medica

PD-L1 Expression (CPS >= 1), +5 more biomarkers

Infiltrating Bladder Urothelial Carcinoma

atezolizumab

immunotherapy

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

~70 mi. (Orbassano, Italy, +154 more cities)

Azienda Sanitaria Ospedaliera S Luigi Gonzaga; S.C.D.U. di Oncologia Toracica

ALK Alternative Transcription Site, +7 more biomarkers

Non-Small Cell Lung Carcinoma

alectinib, +2 more drugs

immunotherapy, +1 more type

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

~70 mi. (Orbassano, Italy, +163 more cities)

Investigational Site Number :3800003

CEACAM5 Expression

Non-Squamous Non-Small Cell Lung Carcinoma

tusamitamab ravtansine

chemotherapy, +1 more type

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer

~70 mi. (Orbassano, Italy, +151 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

niraparib, +1 more drug

immunotherapy, +1 more type

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~70 mi. (Orbassano, Italy, +142 more cities)

AOU San Luigi Gonzaga

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy